These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37107601)

  • 1. Stable Isotope Tracing Reveals an Altered Fate of Glucose in
    Wise JTF; Yin X; Ma X; Zhang X; Hein DW
    Genes (Basel); 2023 Mar; 14(4):. PubMed ID: 37107601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deletion of arylamine N-acetyltransferase 1 in MDA-MB-231 human breast cancer cells reduces primary and secondary tumor growth in vivo with no significant effects on metastasis.
    Doll MA; Ray AR; Salazar-González RA; Shah PP; Vega AA; Sears SM; Krueger AM; Hong KU; Beverly LJ; Hein DW
    Mol Carcinog; 2022 May; 61(5):481-493. PubMed ID: 35133049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic analysis of arylamine
    Hong KU; Gardner JQ; Doll MA; Stepp MW; Wilkey DW; Benz FW; Cai J; Merchant ML; Hein DW
    Toxicol Rep; 2022; 9():1566-1573. PubMed ID: 36158865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Knockout of human arylamine N-acetyltransferase 1 (NAT1) in MDA-MB-231 breast cancer cells leads to increased reserve capacity, maximum mitochondrial capacity, and glycolytic reserve capacity.
    Carlisle SM; Trainor PJ; Doll MA; Stepp MW; Klinge CM; Hein DW
    Mol Carcinog; 2018 Nov; 57(11):1458-1466. PubMed ID: 29964355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dataset for proteomic analysis of arylamine
    Hong KU; Gardner JQ; Doll MA; Stepp MW; Wilkey DW; Benz FW; Cai J; Merchant ML; Hein DW
    Data Brief; 2022 Dec; 45():108634. PubMed ID: 36426076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 knockout of human arylamine N-acetyltransferase 1 in MDA-MB-231 breast cancer cells suggests a role in cellular metabolism.
    Carlisle SM; Trainor PJ; Hong KU; Doll MA; Hein DW
    Sci Rep; 2020 Jun; 10(1):9804. PubMed ID: 32555504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of cytidine deaminase in NAT1 knockout breast cancer cells.
    Hong KU; Tagnedji AH; Doll MA; Walls KM; Hein DW
    J Cancer Res Clin Oncol; 2023 Jul; 149(8):5047-5060. PubMed ID: 36329350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Arylamine
    Carlisle SM; Trainor PJ; Doll MA; Hein DW
    Front Pharmacol; 2021; 12():803254. PubMed ID: 35046826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and small molecule inhibition of arylamine N-acetyltransferase 1 reduces anchorage-independent growth in human breast cancer cell line MDA-MB-231.
    Stepp MW; Doll MA; Carlisle SM; States JC; Hein DW
    Mol Carcinog; 2018 Apr; 57(4):549-558. PubMed ID: 29315819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untargeted polar metabolomics of transformed MDA-MB-231 breast cancer cells expressing varying levels of human arylamine
    Carlisle SM; Trainor PJ; Yin X; Doll MA; Stepp MW; States JC; Zhang X; Hein DW
    Metabolomics; 2016 Jul; 12(7):. PubMed ID: 27872580
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Stepp MW; Salazar-González RA; Hong KU; Doll MA; Hein DW
    J Oncol; 2019; 2019():3860426. PubMed ID: 31531019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arylamine N-acetyltransferase 1 deficiency inhibits drug-induced cell death in breast cancer cells: switch from cytochrome C-dependent apoptosis to necroptosis.
    McAleese CE; Butcher NJ; Minchin RF
    Breast Cancer Res Treat; 2022 Oct; 195(3):223-236. PubMed ID: 35918499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of human arylamine N-acetyltransferase I knockdown in triple-negative breast cancer cell lines.
    Tiang JM; Butcher NJ; Minchin RF
    Cancer Med; 2015 Apr; 4(4):565-74. PubMed ID: 25627111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arylamine
    Li P; Butcher NJ; Minchin RF
    Mol Pharmacol; 2019 Nov; 96(5):573-579. PubMed ID: 31444237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arylamine N-acetyltransferase 1 protects against reactive oxygen species during glucose starvation: Role in the regulation of p53 stability.
    Wang L; Minchin RF; Butcher NJ
    PLoS One; 2018; 13(3):e0193560. PubMed ID: 29518119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo metabolic flux profiling with stable isotopes discriminates sites and quantifies effects of mitochondrial dysfunction in C. elegans.
    Vergano SS; Rao M; McCormack S; Ostrovsky J; Clarke C; Preston J; Bennett MJ; Yudkoff M; Xiao R; Falk MJ
    Mol Genet Metab; 2014 Mar; 111(3):331-341. PubMed ID: 24445252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect arylamine N-acetyltransferase 1 on morphology, adhesion, migration, and invasion of MDA-MB-231 cells: role of matrix metalloproteinases and integrin αV.
    Li P; Butcher NJ; Minchin RF
    Cell Adh Migr; 2020 Dec; 14(1):1-11. PubMed ID: 31910058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiolipin-induced activation of pyruvate dehydrogenase links mitochondrial lipid biosynthesis to TCA cycle function.
    Li Y; Lou W; Raja V; Denis S; Yu W; Schmidtke MW; Reynolds CA; Schlame M; Houtkooper RH; Greenberg ML
    J Biol Chem; 2019 Jul; 294(30):11568-11578. PubMed ID: 31186346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Untargeted stable isotope-resolved metabolomics to assess the effect of PI3Kβ inhibition on metabolic pathway activities in a PTEN null breast cancer cell line.
    Lackner M; Neef SK; Winter S; Beer-Hammer S; Nürnberg B; Schwab M; Hofmann U; Haag M
    Front Mol Biosci; 2022; 9():1004602. PubMed ID: 36310598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the metabolic phenotype of breast cancer cells by multiple tracer stable isotope resolved metabolomics.
    Lane AN; Tan J; Wang Y; Yan J; Higashi RM; Fan TW
    Metab Eng; 2017 Sep; 43(Pt B):125-136. PubMed ID: 28163219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.